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Cellular Delivery of MRI Contrast Agents
agents that allow for the observation of developmentalMatthew J. Allen,1,3 Keith W. MacRenaris,3
P.N. Venkatasubramanian,2 events in vivo [6, 7].
A principal barrier to the further development of newand Thomas J. Meade1,3,*
1Departments of Chemistry, Biochemistry and contrast agents for the investigation of developmental
biological questions is the ability to transport the agentsMolecular and Cell Biology, Neurobiology and
Physiology, and Radiology across cellular membranes. The majority of MRI contrast
agents are restricted to the extracellular domains, andNorthwestern University
2145 Sheridan Road there are few examples of membrane permeable MR
contrast agents reported in the literature [8–15]. As partEvanston, Illinois 60208
2 Center for Basic MR Research of our research in preparing contrast agents that cross
cell membranes, we are investigating a number of smallENH Research Institute
Evanston, Illinois 60201 molecules that facilitate transport of charged and un-
charged species.
The recent development of MR contrast agents that
can be used to detect biological processes, such asSummary
-galactosidase activity, has provided the means to ob-
tain direct physiological information in the form of aMagnetic resonance imaging (MRI) is a powerful tool
for acquiring images of opaque living animals with the three-dimensional image [16, 17]. A major limitation of
these bioactivated agents is their strictly extracellularbenefit of tracking events over extended periods of
time on the same specimen. Contrast agents are used nature. Our goal in synthesizing contrast agents that
permeate cell membranes is to deliver these agentsto enhance regions, tissues, and cells that are magnet-
ically similar but histologically distinct. A principal bar- inside the cell. Accomplishing this goal will allow for the
detection of biologically important intracellular mole-rier to the development of MRI contrast agents for
investigating biological questions is the delivery of cules with MRI, such as enzyme reporters and second-
ary messengers.agents across cellular membranes. Here, we describe
the synthesis and in vitro testing of Gd(III)-based MRI Recently, we have reported a polyarginine-based MRI
contrast agent that is able to permeate cell membranes.contrast agents containing varying length polyarginine
oligomers capable of permeating cell membranes. We We demonstrated the use of two-photon laser micros-
copy and T1 analysis as a means to observe this processexamine the effect of the length of oligomer on T1
enhancement and cellular uptake. Furthermore, the [8]. This work expands on that report through the synthe-
sis and thorough testing of a series of membrane-per-effect of incubation time, concentration, and cell type
on uptake is explored. Toxicity and washout studies meable polyarginine oligomers of varying lengths cova-
lently attached to a chelate framework that coordinatesare performed in addition to MRI phantom studies.
a lanthanide ion to the chelate 1,4,7,10-tetraazacyclo-
dodecane -N,N,N″,N″-tetraacetic acid (DOTA). The se-Introduction
lection of polyarginine (8, 12, and 16 monomer units) is
due to published work that demonstrates the ability ofThe field of developmental biology has undergone sig-
nificant advances using biological molecular imaging these compounds to cross cell membranes [18, 19]. The
mechanism of this delivery is not completely under-techniques such as computer-enhanced light micros-
copy imaging, positron emission tomography (PET), mi- stood; however, it is not a result of adsorptive- or recep-
tor-mediated endocytosis [19]. We report the synthesiscro CT, and magnetic resonance imaging (MRI) [1–4].
Of these techniques, MRI has proven to be a particularly and thorough cell culture testing of series of lanthan-
ide(III)-based MRI contrast agents conjugated to polyar-powerful tool in clinical and biological settings because
of its ability to noninvasively attain internal images. MRI ginine that are able to permeate cell membranes. The
synthesis and physical properties of three agents areoffers a noninvasive means of acquiring three-dimen-
sional images that can map structure and function in compared, and their behavior in cell culture is thoroughly
examined.vivo. Images are based upon the NMR signal from the
protons of water molecules, where the signal intensity
in a given volume element is a function of the water
Resultsconcentration and relaxation times (T1 and T2). Intrinsic
contrast can be enhanced by using paramagnetic con-
Compounds 1–9 were synthesized as shown in Figuretrast agents. The paramagnetic ion gadolinium Gd(III)
1. Standard peptide synthesis techniques were used tois used commonly in MRI contrast agents to provide
prepare 8, 12, and 16 amino acid polyarginine oligomers,increased contrast by decreasing the local T1 of nearby
which were subsequently conjugated to DOTA(tris-t-Buwater protons [5]. Our group has prepared MRI contrast
ester) [20]. The conditions used to cleave the peptides
from the resin simultaneously deprotected the t-butyl*Correspondence: tmeade@northwestern.edu
esters on the ligand. The desired lanthanide ion was3 Division of Biology and the Beckman Institute, California Institute
of Technology, Pasadena, California 91125. added using the appropriate lanthanide hydroxide. Li-
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Figure 1. Synthesis of Polyarginine-Containing Lanthanide Che-
lates
(a) (1) Piperidine, DMF (2) Fmoc-R(Pbf)-OH, HATU, DMF, DIPEA; (b)
(1) piperidine, DMF (2) DOTA(tris-t-Bu ester), HATU, DMF, DIPEA (3)
95% TFA, 2.5% H2O, 2.5% TIS; (b) Eu(OH)3 or Gd(OH)3 in water at
80C for 12 hr.
gands were characterized using 1H NMR spectroscopy
and mass spectrometry, and final products were purified
on a Sephedex G-25 column and characterized by mass
spectrometry.
Relaxivity measurements were acquired by taking the
slope of a plot of T11 versus concentration. Measure-
ments were taken in 10 mM 3-(N-morpholino)propane
sulfonic acid (MOPS), 100 mM sodium chloride, 20 mM
sodium bicarbonate, and 4 mM sodium phosphate mo-
nobasic at pH 7.41, 59.97 MHz, and 37C. Since the
exact nature of the counter-anion to arginine was not
known, gadolinium concentrations for relaxivity mea-
surements were determined by ICP of the measured
solutions. There is a high probability that the counter-
anions were TFA [21, 22]. Determination of the gadolin-
ium concentration by ICP-MS allows for the calculation
of the molar concentration without knowing the exact
identity of the counter-anions.
Octanol-water partition coefficients were obtained by
dissolving 7–12 mg of 4, 5, or 6 into mixtures of 500 l
water and 500 l 1-octanol. The resulting mixture was
shaken vigorously for 2 hr on a Lab-Line lab rotator
(model number 1304). The solvent layers were allowed
to separate, and 400 l of each layer was removed. The
solvent was removed under reduced pressure, and the
mass of material from each layer was measured. The Figure 2. Demonstration of the Dependence of Uptake of 4–6 on
reported values are for the mass of compound in the Incubation Concentration
1-octanol layer divided by the mass of compound in After incubation, NIH/3T3 cells were rinsed with DPBS, treated with
the water layer. All octanol-water measurements were trypsin, dissolved in nitric acid, and analyzed with ICP-MS. The
repeated in triplicate, and the average value is reported. graphs show uptake per cell plotted against incubation concentra-
tion. Error bars represent one standard deviation.Relaxivity values and octanol-water partition coeffi-
cients are listed in Table 1.
All cell experiments described in this paper were re-
Table 1. Relaxivity Values and Octanol-Water Partition
peated in at least triplicate. The gadolinium(III) com-Coefficients Measured for 4, 5, and 6
plexes, 4–6, were synthesized as MRI contrast agents.
Relaxivity Octanol-Water Because europium(III) is similar in size to gadolinium(III)
Compound (mM1s1) Partition Coefficient but with different fluorescent properties, europium(III)
4 6.8 0.0233  0.0003 complexes can be used for fluorescence microscopy
5 4.8 0.117  0.039 [8]. The europium(III) complexes, 7–9, were synthesized
6 4.4 0.104  0.068 as fluorescence microscopy dyes; however, because a
Relaxivity was measured at 59.97 MHz and 37C in 10 mM MOPS, change in the lanthanide ion should not affect the deliv-
100 mM NaCl, 20 mM NaHCO3, and 4 mM NaH2PO4 at pH 7.41. ery properties of the polyarginine-containing contrast
Values for partition coefficients are plus or minus one standard agent, complexes 4–9 were all used in some cell experi-
deviation.
ments.
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Figure 3. Washout Rate of 4–6 from NIH/3T3
Cells as a Function of the Number of Rinses
Cells were incubated for 1 hr, and then me-
dium was changed. After each rinse period,
the medium was removed and analyzed using
ICP-MS. Long incubation times were 24, 48,
72, and 96 hr. Short incubation times were
1, 3, 6, and 10 hr. Error bars represent one
standard deviation.
To determine the toxicity of 7, 8, and 9, a 3-(4,5- incubator. At the end of the incubation period, the me-
dium was removed and the cells were rinsed in triplicatedimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT)
assay was performed. Mouse fibroblast, NIH/3T3 cells with DPBS at ambient temperature. The cells were ex-
posed to 250l of 0.25% trypsin and harvested, at whichwere plated at 150,000 cells/ml in a Costar 96-well plate
(polystyrene, flat bottom, tissue-culture treated, black point they were counted using a hemacytometer and
checked for viability using a trypan blue assay [23]. Thewith clear bottom) and incubated overnight. Solutions
of 7, 8, and 9 in DPBS were added to the wells to give average number of cells per flask ranged from 4,500 to
15,000 and increased with increasing incubation time.concentrations ranging from 1 mM to 44 mM. The plate
was incubated for 1 hr, at which point 10 l of MTT was All cells were 98% viable after exposure to 7, 8, or 9
by trypan blue assay. The trypsin/cell suspensions wereadded to each well and incubated for 4 hr at 37C in a
5% carbon dioxide incubator. The detergent reagent incubated with 500 l of concentrated nitric acid at 80C
for 4 hr. The dissolved cells were diluted to 10 ml. Thesupplied with the MTT assay kit (100 l) was added to
each well and incubated in the dark at ambient tempera- final cell solutions were in 3% nitric acid with 5 ppb
of indium as an internal standard. The samples wereture overnight. The absorbance at 570 nm was measured
with background subtraction and used to determine tox- analyzed by ICP-MS. The amount of gadolinium per cell
was calculated, and no significant difference of uptakeicity. None of the compounds affected cell proliferation
below 10 mM. of gadolinium per cell was observed between any of the
incubation times.To examine the effect of contrast agent concentration
on cellular uptake, ICP-MS was utilized. NIH/3T3 cells In studying the rate at which the polyarginine contrast
agents leached from the cells, ICP-MS was used. NIH/were grown in Costar 96-well plate (polystyrene, flat
bottom, tissue-culture treated, black with clear bottom) 3T3 cells, which exhibit contact-inhibited growth, were
grown in Corning brand tissue culture flasks (25 cm2with modified DMEM containing 10% BCS in a 5% car-
bon dioxide incubator. Cells were incubated with 4, 5, with vent cap) with modified DMEM containing 10% BCS
in a 5% carbon dioxide incubator. A monolayer of cellsor 6 for 1 hr at 37C with concentrations of 0.01, 0.1,
0.5, 3, and 10 mM in modified DMEM containing 10% was incubated with 4, 5, or 6 (0.3 mM in modified DMEM
containing 10% BCS) for 1 hr at 37C in a 5% carbonBCS in a 5% carbon dioxide incubator. At the end of
the incubation period, the medium was removed, and dioxide incubator. At the end of the incubation period,
the medium was removed and the cells were rinsedthe cells were rinsed in triplicate with DPBS at ambient
temperature. The cells were exposed to 100 l of 0.25% in triplicate with DPBS at ambient temperature. Fresh
medium (5 ml) was applied to the cells, and they weretrypsin and harvested; they were then counted using a
hemacytometer. There was an average of 140,000 cells returned to the incubator. After periods of 24, 48, 72,
and 96 hr, the medium was removed and replaced withper well. The trypsin/cell suspensions were incubated
with concentrated nitric acid at 80C for 4 hr. The dis- fresh medium after triplicate rinsing with DPBS. The
removed medium was analyzed for gadolinium concen-solved cells were diluted to 5 ml. The final cell solutions
were in 3% nitric acid with 5 ppb of indium as an internal tration using ICP-MS. After removal of the medium at
96 hr, the cells were exposed to trypsin and preparedstandard. The samples were analyzed by ICP-MS. The
amount of gadolinium per cell was calculated and is for ICP-MS as described previously. This process was
repeated with sampling times of 1, 3, 6, and 10 hr. Theshown in Figure 2.
In determining the effect of incubation time on uptake results of these experiments are shown in Figure 3. The
amount of gadolinium remaining in the cells after 96 hrof the polyarginine contrast agents, ICP-MS was uti-
lized. NIH/3T3 cells were grown in Corning brand tissue was 3  1019–5  1019 mol/cell for all three com-
pounds.culture flasks (25 cm2 with vent cap) with modified
DMEM containing 10% BCS in a 5% carbon dioxide To determine if the uptake of the polyarginine contrast
agents was specific to NIH/3T3 cells, the uptake of 7,incubator. Cells were incubated with 7, 8, or 9 (0.3 mM
in modified DMEM containing 10% BCS) for periods of 8, and 9 was examined using NIH/3T3, canine kidney
epithelial (MDCK), and mouse macrophage (RAW 264.7)0.5, 1, 2, 4, 10, or 24 hr at 37C in a 5% carbon dioxide
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Figure 5. Results of T1 Study of NIH/3T3 Cells Incubated with 0.3
Figure 4. Cell-Type Specificity for 7–9 mM 4, 5, 6, and Gd(III) DO3A (1,4,7-Tris-Carboxymethyl-1,4,7,10-
Tetraazacyclododecane)Cells were incubated with compound for 1 hr and rinsed with DPBS,
treated with trypsin, dissolved in nitric acid, and analyzed with ICP- After incubation, cells were rinsed with DPBS. T1 values were mea-
MS. The graph shows uptake per cell for each cell type plotted sured at 60 MHz and 37C. The graph depicts the percent change
against complex. Incubation concentration of 7-9 was constant in T1 from untreated NIH/3T3 cells. Values for GdDO3A are from
within each group of cells but was not constant from compound to [28]. Error bars represent one standard deviation.
compound. Error bars represent one standard deviation.
0.21 s for 6, and 3.96  0.01 s for untreated cells. The
results of these experiments are shown in Figure 5.
cells. Cells were grown in Costar 12-well plates (polysty- To determine the viability of these agents for MRI,
rene, tissue-culture treated) in a 5% carbon dioxide incu- NIH/3T3 cells were grown in Corning brand tissue cul-
ture flasks (75 cm2 with vent cap) using modified DMEMbator at 37C with modified DMEM containing 10% BCS
containing 10% BCS. Cells were incubated with 3 mMfor the NIH/3T3 cells, EMEM modified to contain 1.0 mM
4 in modified DMEM containing 10% BCS for 1 hr atsodium pyruvate, 0.1 mM nonessential amino acids, and
37C in a 5% carbon dioxide incubator, at which time1.5 g/l sodium bicarbonate, supplemented with 10%
they were rinsed three times with DPBS (2–3 ml) main-FBS for the MDCK cells and modified DMEM containing
tained at ambient temperature. The cells were exposed10% FBS for the RAW 264.7 cells. Cells were incubated
to 1 ml of 0.25% trypsin and harvested, then countedwith 7, 8, or 9 in the appropriate medium for 1 hr at 37C
using a hemacytometer. An average of 5,000,000 cellsin a 5% carbon dioxide incubator. At the end of the
were loaded into NMR tube coaxial inserts (catalog num-incubation period, the medium was removed and the
ber WGS-5BL, Wilmad, NJ) as trypsin suspensions.cells were rinsed in triplicate with DPBS at ambient tem-
Spin-lattice relaxation time (T1) of unlabeled cells wasperature. NIH/3T3 and MDCK cells were exposed to
2.53  0.21 s. Labeling with 4 resulted in the reduction0.25% trypsin, and RAW264.7 cells were removed using
of T1 to 1.64  0.03 s. Based on this difference in T1a cell scraper. The cell suspensions were prepared for
values, contrast between treated and untreated cellsICP-MS as described previously. The samples were ana-
was generated in T1-weighted spin-echo images usinglyzed by ICP-MS, and the amount of gadolinium per cell
a short recycle time (TR) of 500 ms. The result of thewas calculated and is shown in Figure 4.
imaging experiment is shown in Figure 6. It can be seenTo determine the effect of varying polyarginine oligo-
mer length on T1 enhancement upon uptake by NIH/3T3
cells, experiments were performed using a Bruker mq
60 NMR Analyzer. NIH/3T3 cells were grown in Corning
brand tissue culture flasks (75 cm2 with vent cap) using
DMEM modified to contain 4 mM L-glutamine, 4.5 g/l
glucose, and 1.5 g/l sodium bicarbonate, supplemented
with 10% BCS. Cells were incubated with 0.3 mM 4, 5,
or 6 in modified DMEM containing 10% BCS for 1 hr at
37C in a 5% carbon dioxide incubator, at which time
they were rinsed three times with DPBS (2–3 ml) main-
tained at ambient temperature to insure removal of ex-
tracellular and unbound contrast agent. The cells were
exposed to 250 l of 0.25% trypsin and harvested; they
were then counted using a hemacytometer and checked
Figure 6. T1-Weighted Spin-Echo MR Images of NIH/3T3 Cells atfor viability using a trypan blue assay [23]. There was
9.4 Tan average of 1,000,000 cells per flask, and all cells
Images were obtained using a spin-echo pulse sequence with TRwere 98% viable after exposure to 4, 5, or 6 by trypan
500 ms, echo delay time (TE) 16 ms.blue assay. The T1 of the trypsin/cell suspensions were (A) NIH/3T3 cells incubated with 4.
measured. Untreated cells were examined in an analo- (B) Untreated NIH/3T3 cells.
gous fashion. The average T1 of the cell suspensions (C) Deionized water in a capillary tube as a spatial marker. The scale
bar represents 1.2 mm.were 3.06  0.13 s for 4, 3.13  0.41 s for 5, 3.22 
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from the image that the signal intensity of the untreated per cell was not dependent on the length of incubation
when monitored from 0.5–24 hr. However, the washoutcells is similar to that of deionized water, which has a
rate of 4–6 was dependent on time and the number oflong T1. Both untreated cells and deionized water appear
rinses. This dual dependence is shown in Figure 3, indark; in contrast, the intensity of treated cells is higher
which the total amount of gadolinium released from anby a factor of three and they appear bright. Treatment
entire plate of cells is plotted against the number ofof NIH/3T3 cells with 4 decreases the T1 of the cells and
rinses and the duration of the rinses. For both long timerenders them bright in a T1-weighted MR image.
medium changes (24, 48, 72, 96 hr) and short time me-
dium changes (1, 3, 6, 10 hr), more compound leached
from the cells on the first rinse (24 hr or 1 hr) than onDiscussion
subsequent rinses. Washout from the cells for subse-
quent rinses remained constant. The difference in theThe relaxivities and octanol-water partition coefficients
amount released between the first and subsequentof 4–6 are listed in Table 1. The values for relaxivity
rinses was larger for the long times than the short times.range from 4.4 mM1s1 to 6.8 mM1s1, with the longer
Additionally,99% of the gadolinium was released frompolyarginine oligomers having smaller relaxivities. These
the cells by the end of the fourth rinse (calculated usingvalues are slightly higher but on the same order of mag-
the residual gadolinium content at the end of the experi-nitude as Prohance, which has a relaxivity of 3.1
ment and the amount of gadolinium taken up by themM1s1 when measured at the same field strength,
cells in Figure 2). These results demonstrate that theretemperature, and in the same buffer. This result demon-
is both time dependence and dependence on the num-strates that complexes 4–6 can be used as effective
ber of rinses for the washout of 4–6.MRI contrast agents.
Three cell types (NIH/3T3, RAW 264.7, and MDCK)The octanol-water partition coefficients are all less
were incubated with 7–9 to determine if uptake of thethan one, with the value for 4 less than the values of 5 and
agents was cell-type specific (Figure 4). The experiment6. The partition coefficient is a measure of hydrophilicity,
demonstrated that 7–9 were taken up by all three celland the values measured show that the smaller (n 	 8)
types and that there was a difference in the amount ofpolyarginine complex is more hydrophilic than the larger
agent taken up per cell. The highest loading of agent(n 	 12, 16) oligomers. This is a fascinating result be-
was seen in NIH/3T3 cells, and the lowest loading wascause the hydrophilicity would be expected to increase
seen in RAW 264.7 cells. The smaller amount take upwith the addition of the hydrophilic amino acid arginine.
per cell for the RAW 264.7 cells likely is due, at least inInterestingly, no direct correlation between the octanol-
part, to the smaller size of these cells relative to thewater partition coefficients of these complexes and
other two cell types. The uptake trend between cell linesmembrane permeability was found. This supports previ-
was the same for all of the three compounds tested.ous reports that octanol-water partition coefficients
To examine the relative effect on T1 of 4–6, NIH/3T3alone are not a reliable indicator of membrane perme-
cells were analyzed by T1 analysis (Figure 5). Cellsability, and other factors must be taken into account
treated with 4–6 and rinsed with medium had signifi-
when predicting membrane permeability [24–26].
cantly shorter T1 values than untreated control cells andTo determine the toxicity of 4–9, MTT and trypan blue cells treated with the extracellular contrast agent gado-
assays were performed. An MTT proliferation assay was linium(III) 1,4,7,10-tetraazacyclododecane-1,4,7-trisacetic
performed with 7–9 which demonstrated that all com- acid (GdDO3A); however, no significant difference was
pounds did not affect cell proliferation or viability of NIH/ detected between cells treated with 4–6 (95% confi-
3T3 cells up to 10 mM. Above 10 mM, cells began to dence for 5 degrees of freedom in a Student’s t test) [27].
show signs of death, both in morphology and through This experiment demonstrates that all three contrast
a decrease in absorbance in the MTT assay. Trypan agents should equally enhance contrast in MRI.
blue viability studies were performed on all experiments MRI studies were performed to examine the ability of
discussed in this paper. All cells, regardless of type, 4 to enhance contrast in an MRI image of NIH/3T3 cells
incubated with 4–9 at concentrations up to 10 mM, and (Figure 6). This experiment demonstrated that cells
for all incubation times studied were at least 98% viable. treated with polyarginine-based contrast agents show
Since 4–9 were found not to affect cell proliferation increased contrast in an MR image. Importantly, the
or viability up to 10 mM, a range of concentrations from concentration used in this experiment was well below
0.01 mM to 10 mM were tested to determine the amount the level toxic to cells. The results of this experiment,
of material taken up by NIH/3T3 cells as a function of together with the results of other experiments, suggest
concentration. The trends for compounds 4–6 were very that polyarginine-containing contrast agents are cell-
similar (Figure 2). Uptake at low concentrations (0.01–0.1 type specific because they label some cell types more
mM) was minimal and did not appear to change. From heavily than others. Additionally, the time necessary to
0.1 mM to 3 mM, a dramatic increase in uptake occurred, label cells enough to be visualized by MRI is short (
0.5
corresponding to increasing incubation concentration. hr). This is a critical experiment that demonstrates the
This trend ceased at 3 mM, at which point no increase ability of these agents to be employed in the study of
in uptake was observed with increasing concentration. biological phenomena using MRI.
ICP-MS was used in this study because of the facile
manner with which it allows for extreme accuracy and Significance
precision in measuring a large quantity of samples
quickly. The preparation of a reliable intracellular delivery for
probes offers the hope for an extremely powerful toolInterestingly, the amount of contrast agent taken up
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DMF (5 ml) were combined, and diisopropylethylamine (DIPEA) (1.6for the study of in vivo biological activity and is the
ml, 9.2 mmol) was added. The resulting solution was added to thesubject of ongoing work in our laboratory. This work
resin and allowed to react under argon for 3 hr. The resin was draineddiscusses the synthesis and physical characterization
and rinsed four times with DMF. This procedure was repeated six
of a series of three MRI contrast agents that are able times to yield a Fmoc protected 8-mer of polyarginine bound to
to permeate cell membranes. The behavior of these Wang resin. The resin was treated with piperidine and washed with
DMF as described above. In a separate vial, 1,4,7,10-tetraazacyclo-modified MR agents in cell culture is examined in
dodecane-1,4,7-tris(acetic acid-t-butyl ester)-10-acetic acid [DOTAdepth. The cell culture properties of the agents were
(tris-t-Bu ester)] (1.1 g, 2.0 mmol), HATU (0.72 g, 1.9 mmol), andexamined using ICP-MS and T1 analyses as well as
DMF (5 ml) were combined, and DIPEA (1.7 ml, 10 mmol) was added.MRI. The properties of the lanthanide complexes de-
The resulting solution was added to the resin and allowed to react
scribed in this paper are well suited for use in the under argon for 12 hr. The solvent was removed and the resin was
study of biological systems with MRI. washed four times with DMF, four times with dichloromethane, four
times with methanol, and dried under vacuum. A 30 ml solution of
95% trifluoroacetic acid (TFA), 2.5% triisopropylsilane, and 2.5%Experimental Procedures
water was added to the resin and mixed for 1 hr, then drained. The
resin was rinsed with 15 ml TFA. The filtrate and rinse were combinedAll reagents and solvents were the highest commercially available
and reduced in volume to 10 ml. Forty milliliters of 20C methylgrades and were used without further purification. 1,4,7,10-tetraaza-
tert-butyl ether (MTBE) was added to precipitate a white solid. Thecyclododecane-1,4,7-tris(acetic acid-t-butyl ester)-10-acetic acid
solid was washed three times with cold MTBE, taken up in water,[DOTA(tris-t-Bu ester)] was purchased from Macrocyclics (Dallas,
and freeze dried to a white powder. The white powder was exposedTX). Resins and amino acids were purchased from Novabiochem
to the TFA solution for 7 hr, washed with cold MTBE as above, and(San Diego, CA). NIH/3T3 cells, MDCK cells, RAW 264.7 cells, MTT
freeze dried to yield a white solid. Yield 	 1.31 g. 1H NMR (D2O):assay kit, Dulbecco’s modified Eagle’s medium (DMEM) with 4 mM
 	 1.63 (m, 16H), 1.80 (m, 16H), 2.6-3.8 (m, 24H), 3.18 (m, 16H),L-glutamine modified to contain 4.5 g/l glucose and 1.5 g/l sodium
4.30 (m, 8H); MS calculated for C64H124N36O16 [M  H]: 1654.0,bicarbonate, and Eagle’s minimal essential medium (EMEM) with
found 1653.8.Earle’s BSS and 2 mM L-glutamine modified to contain 1.0 mM
sodium pyruvate, 0.1 mM nonessential amino acids, and 1.5 g/l
sodium bicarbonate were purchased from ATCC (Manassas, VA).
DOTA-(Arginine)12 (2)Dulbecco’s phosphate buffered saline (DPBS) w/o calcium and mag-
Polystyrene-based Wang resin containing an Fmoc protected argi-nesium, fetal bovine serum (FBS), bovine calf serum (BCS), 0.25%
nine residue (1.7 g, 0.50 mmol/g) was swelled in dichloromethanetrypsin, trypan blue, vent-cap flasks, multiwell plates, and cell scrap-
for 30 min and washed four times with peptide synthesis gradeers were purchased from Fisher Scientific. All other starting materi-
DMF. The resin was treated twice with a solution of 20% piperidineals were purchased from Aldrich (Milwaukee, WI). Compounds 3, 6,
(20 ml) in DMF for 10 min. The resin was washed four times with9, and europium(III) hydroxide were synthesized following previously
DMF. In a separate vial, Fmoc protected arginine (3.0 g, 4.6 mmol),published procedures [8].
HATU (1.7 g, 4.4 mmol), and DMF (5 ml) were combined, and DIPEA1H NMR spectra were obtained on a Varian mercury spectrometer
(1.6 ml, 9.2 mmol) was added. The resulting solution was added toat 300 MHz for verification of synthesis. Spectra were obtained
the resin and allowed to react under argon for 3 hr. The resin wasin D2O using a value of 4.80 ppm as an internal reference. Mass
drained and rinsed four times with DMF. This procedure was re-spectrometry samples were analyzed using electrospray (ESI) ion-
peated ten times to yield a Fmoc protected 12-mer of polyarginineization, quadrupole mass spectrometry, or matrix-assisted laser de-
bound to Wang resin. The resin was treated with piperidine andsorption ionization time of flight (MALDI-TOF) mass spectrometry in
washed with DMF as described above. In a separate vial, [DOTA(tris-the PPMAL—Protein/Peptide MicroAnalytical Laboratory, California
t-Bu ester)] (1.1 g, 2.0 mmol), HATU (0.72 g, 1.9 mmol), and DMF (5Institute of Technology, Beckman Institute. Results reported for m/z
ml) were combined, and DIPEA (1.7 ml, 10 mmol) was added. Theare for [M  H]. Cells were counted using a Bright-Line hemacy-
resulting solution was added to the resin and allowed to react undertometer. MTT assays were performed using a Bio-Tek Synergy HT
argon for 12 hr. The solvent was removed, and the resin was washedplate reader. Inductively coupled plasma mass spectrometry (ICP-
four times with DMF, four times with dichloromethane, four timesMS) was performed either at Desert Analytics Laboratory (Tucson,
with methanol, and dried under vacuum. A 30 ml solution of 95%AZ) or at Northwestern University’s Analytical Services Laboratory
TFA, 2.5% triisopropylsilane, and 2.5% water was added to the resin(ASL) on a PQ ExCell Inductively Coupled Plasma Mass Spectrome-
and mixed for 1 hr, then drained. The resin was rinsed with 15 mlter. The longitudinal water proton relaxation rate at 59.97 MHz was
TFA. The filtrate and rinse were combined and reduced in volumemeasured using a Bruker mq60 NMR Analyzer (Bruker Canada, Mil-
to 10 ml. Forty milliliters of 20C MTBE was added to precipitateton, Ontario, Canada) operating at 1.5 T, by means of the standard
a white solid. The solid was washed three times with cold MTBE,inversion-recovery technique (20 data points, 8 scans each). A typi-
taken up in water, and freeze dried to a white powder. The whitecal 90 pulse length was 6.16 s, and the reproducibility of the T1
powder was exposed to the TFA solution for 7 hr, washed with colddata was 0.3%. Temperature was maintained at 37C. MR studies
MTBE as above, and freeze dried to yield a white solid. Yield 	were performed on a General Electric/Bruker, Omega 400 WB im-
1.67 g. 1H NMR (D2O):  	 1.62 (m, 24H), 1.79 (m, 24H), 2.6-3.8 (m,aging spectrometer fitted with Accustar shielded gradients at ambi-
24H), 3.17 (m, 24H), 4.27 (m, 12H); MS calculated for C88H172N52O20ent temperature (20C). Spin-lattice relaxation time was measured
[M  H]: 2279.7, found 2280.0.using an inversion recovery pulse sequence. Images were acquired
using a spin-echo imaging pulse sequence. MR measurements were
carried out on freshly harvested cells. Cells were allowed to settle General Lanthanide(III) Complex Synthesis
in NMR sample tubes under gravitational force prior to their place- To a solution of the free ligand in water (16–32 mM) was added
ment in the magnet. gadolinium(III) hydroxide or europium(III) hydroxide (1.3 equiv.). The
reaction mixture was heated to 80C and stirred for 12 hr. The
reaction mixture was then cooled to ambient temperature, and the HDOTA-(Arginine)8 (1)
Polystyrene-based Wang resin containing an Fmoc protected argi- was adjusted to 11 with aqueous ammonium hydroxide. The mixture
was filtered through a 0.2m syringe filter, purified using Sephedex-nine residue (1.7 g, 0.50 mmol/g) was swelled in dichloromethane
for 30 min and washed four times with peptide synthesis grade G25 size exclusion chromatography, and freeze dried to yield a
white solid.dimethylformamide (DMF). The resin was treated twice with a solu-
tion of 20% piperidine (20 ml) in DMF for 10 min. The resin was DOTA-(Arginine)8 Gadolinium(III) (4)
Yield: 0.618 g (86.7%). MS calculated for C64H120GdN36O16 [M  H]:washed four times with DMF. In a separate vial, Fmoc protected
arginine (3.0 g, 4.6 mmol), O-(7-azabenzotriazol-1-yl)-1,1,3,3-tetra- Gd isotope pattern centered at 1808.1, found Gd isotope pattern
centered at 1808.1.methyluronium hexafluorophosphate (HATU) (1.7 g, 4.4 mmol), and
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DOTA-(Arginine)12 Gadolinium(III) (5) imaging of T cells loaded with HIV transactivator-peptide-
derived superparamagnetic nanoparticles. J. Immunol. Meth-Yield: 0.651 g (68.3%). MS calculated for C88H168GdN52O20 [M  H]:
Gd isotope pattern centered at 2432.9, found Gd isotope pattern ods 256, 89–105.
14. Kayyem, J.F., Kumar, R.M., Fraser, S.E., and Meade, T.J. (1995).centered at 2432.9.
DOTA-(Arginine)8 Europium(III) (7) Receptor-targeted co-transport of DNA and magnetic reso-
nance contrast agents. Chem. Biol. 2, 615–620.Yield: 0.466 g (80.7%). MS calculated for C64H120EuN36O16 [M  H]:
Gd isotope pattern centered at 1802.8, found Gd isotope pattern 15. Heckl, S., Debus, J., Jenne, J., Pipkorn, R., Waldeck, W., Spring,
H., Rastert, R., Von der Lieth, C.W., and Braun, K. (2002).centered at 1802.2.
DOTA-(Arginine)12 Europium(III) (8) CNN-Gd3 enables cell nucleus molecular imaging of prostate
cancer cells: the last 600 nm. Cancer Res. 62, 7018–7024.Yield: 0.527 g (70.0%). MS calculated for C88H168EuN52O20 [M  H]:
Gd isotope pattern centered at 2427.3, found Gd isotope pattern 16. Louie, A.Y., Huber, M.M., Ahrens, E.T., Rothbacher, U., Moats,
R., Jacobs, R.E., Fraser, S.E., and Meade, T.J. (2000). In vivocentered at 2427.0.
visualization of gene expression using magnetic resonance im-
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